Skip to main content
Psychedelic drug

Psychedelic drug

Drug typeWikipedia

Search complete. 73 mentions across 40 episodes found for "Psychedelic drug".

Oct 27, 2026

Ben EverettHOST
7:42
All right, but before we really dive in, I just want to orient a quick note for our listeners.
Ben EverettHOST
7:47
So this episode actually completes a two-part conversation that began a few weeks ago with Dr. Stephen Berkowitz, and he suggested Dr. Thompson might be a better person to take us deeper into CU's psychedelic research program.
Ben EverettHOST
8:00
So with that, let's really – I want to talk about the CU program because I think it is really – a foundational example of what I think psychedelic research programs should look like.
Ben EverettHOST
8:13
It's multidisciplinary.
Ben EverettHOST
8:14
You've got from different backgrounds, from different specialties, all coming together at looking at psychedelics.
Ben EverettHOST
8:20
So maybe if we can start with a 30,000 foot view, you direct the novel therapeutics within CU's Brain and Behavior Innovation Center.
Ben EverettHOST
8:28
So can you orient our listeners to what's happening in psychedelic research within your department and then the psychedelic research consortium more broadly?
Scott ThompsonGUEST
8:38
Yes.
Nate RoseGUEST
32:19
Philosophy took me to a place.
Nate RoseGUEST
32:20
Psychedelics took me to a place.
Nate RoseGUEST
32:23
My friends, great conversation with my friends took me to places.
Nate RoseGUEST
32:26
Yeah.
Ethan KrossGUEST
32:30
So you can get that kind of expansion from the world around us.
Ethan KrossGUEST
32:36
Psychedelics are, anecdotally, I've spoken to a lot of people who have benefited, report benefiting quite a bit from them.
Ethan KrossGUEST
32:46
The experience has been is that it does blur this, like you become merged with something the energy around you.
Ethan KrossGUEST
32:54
And it also puts you in a state of mind that allows some individuals to reframe things more effectively, find insight into their experiences.
Holly WainwrightHOST
29:39
But the thing about this interview is it's not really about that because the reason that Judith Lucy was on the press trail at all when she got her cancer diagnosis, is that she's written a memoir, a book called Well, Well, Well, and it's all about wellness.
Holly WainwrightHOST
29:52
And the tagline for it is My Wellness Odyssey from Psychics to Psychedelics and Beyond.
Holly WainwrightHOST
29:59
So she says that after COVID and various things, she got really burnt out.
Holly WainwrightHOST
30:02
And she said as a Gen X woman, she didn't believe in burnout, which is very typical.
Joseph L. FlatleyHOST
9:13
The magazine was called High Frontiers.
Joseph L. FlatleyHOST
9:16
The full subtitle reads, The Space Age Magazine of Psychedelics, Science, Human Potential, Irreverence, and Modern Art.
Joseph L. FlatleyHOST
9:26
The first issue was published in 1984 on the cheapest paper available.
Joseph L. FlatleyHOST
9:33
High Frontiers issue number one ran interviews with Timothy Leary and Albert Hoffman, who discovered LSD.
Alex NewmanGUEST
47:02
There's witches, there's sorcery, there's blatant attacks on Christianity.
Alex NewmanGUEST
47:07
One of the talks we went to was by the high priest of the Church of Psychedelics.
Alex NewmanGUEST
47:11
And interesting guy.
Alex NewmanGUEST
47:12
He's got about 150,000 members of his so-called church.
JenHOST
28:27
Obviously you guys were the weed school, but there was also a lot, a lot of like shrooms and like people in trees dropping acid and like,
NatalieHOST
28:37
Psychedelics.
NatalieHOST
28:38
Yeah.
NatalieHOST
28:38
You went more hard drugs.
Josh HardmanHOST
0:05
Welcome to the Psychedelic News Feed, a podcast from Psychedelic Alpha.
Josh HardmanHOST
0:09
Each episode brings you up to speed with the latest across psychedelic drug development, policy, and access from around the world.
Josh HardmanHOST
0:16
It's presented by me, Josh Hardman, Psychedelic Alpha's founder and editor.
Josh HardmanHOST
0:21
These are intended to be concise summaries as opposed to deep dives.
Josh HardmanHOST
0:25
If you are looking for more nuanced analysis, exclusive interviews, and unrivaled reporting on these topics and much more, head to psychedelicalpha.com.
Josh HardmanHOST
0:43
Welcome to the third episode of the Psychedelic News Feed podcast, this episode covering October 5th to 18th, 2026.
Josh HardmanHOST
0:52
We have five main stories to run through today and then some additional headlines.
Josh HardmanHOST
0:56
The first is some early notes from the Psychedelic Healthcare Forum that we hosted last week in New York City.
John O'ConnorGUEST
14:21
It just means, you know, the cops aren't going to break down your door looking for your stash of LSD.
John O'ConnorGUEST
14:28
You know, but so I do think, you know, I think we are... are headed to a saner more sober if you will landscape with these with these drugs but it's i don't think it's gonna go quite how cannabis went really quickly um well it was a long it took a long time to get to um to the legislation but once we got there it went state by state and now we have over half states have full legalization with many more kind of decriminalized cannabis use and um Psychedelics will probably follow not exactly the same path, but a similar one.
John O'ConnorGUEST
15:05
In April, President Trump fast-tracked psilocybin and other kinds of psychedelics.
John O'ConnorGUEST
15:15
I think I will gain MDMA, fast-tracked them for FDA approval, specifically to treat PTSD.
Esme DarkHOST
1:09
This episode, we are speaking with Associate Professor Vanessa Beesley.
Esme DarkHOST
1:15
She is a Distinguished Behavioural Scientist and a Team Head of the Psychedelic Medicine and Supportive Care Group at the QIMR Medical Research Institute.
Esme DarkHOST
1:27
She leads the Psilocybin-Assisted Supportive Therapy trial, which looks at the treatment of prolonged grief disorder, and she is the Chief Investigator on a number of other trials.
Esme DarkHOST
1:41
She has a career spanning two decades in psychopharmacology and is committed to person-centred care, addressing supportive care needs for patients and their caregivers.
Esme DarkHOST
4:44
Is that right?
Vanessa BeesleyGUEST
4:46
Yes.
Vanessa BeesleyGUEST
4:46
I'm a behavioural scientist and I am the team head of the Psychedelic Medicine and Supportive Care Group at QRMR Berghofer.
Vanessa BeesleyGUEST
4:55
which is a world-leading medical research institute up in Brisbane.

30 more episodes mention Psychedelic drug.

Create an account to see the whole feed, search across every transcript, and follow the entities you care about.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.